Reactivation of Hepatitis B after Administration of Anti-TNFα in a Patient with Psoriasis

Díaz Corpas, Tania and Mateu Puchades, Almudena and Zayas Gavilá, Ana and Marquina Vila, Amparo (2012) Reactivation of Hepatitis B after Administration of Anti-TNFα in a Patient with Psoriasis. International Journal of Clinical Medicine, 03 (02). pp. 143-144. ISSN 2158-284X

[thumbnail of IJCM20120200011_69197094.pdf] Text
IJCM20120200011_69197094.pdf - Published Version

Download (253kB)

Abstract

In patients with severe psoriasis that at the same time have multiple comorbidities and chronic infections, is difficult to establish safer and more effective therapy. There are contradictions between the indications of the international protocols of systemic treatments, and the most recent publications which show that anti-TNFα agents could be safe therapeutic options in patients with chronic hepatitis. In the case of chronic viral infections, specifically hepatitis B, there are several conflicts in reference to the biological treatments that can block tumoral necrosis factor-α (TNFα) because there is evidence of a risk of reactivation of hepatitis. Most viral reactivations with the administration of an anti-TNFα agent have been reported in patients with inflammatory diseases. However, there are a few cases described in psoriasis. We’ll present the first case reported in literature of hepatisis B viral (HBV) reactivation in a patient with severe psoriasis secondary to the administration of adalimumab.

Item Type: Article
Subjects: ScienceOpen Library > Medical Science
Depositing User: Managing Editor
Date Deposited: 27 Jan 2023 06:24
Last Modified: 17 Jun 2024 06:41
URI: http://scholar.researcherseuropeans.com/id/eprint/213

Actions (login required)

View Item
View Item